Vladislav Bessarabov: “We’re eager to ramp up our presence in Kazakhstan and expand our portfolio”
Vladislav Bessarabov, Head of Strategic Business Unit Eurasia at Bosnalijek, gave an interview to Natalia Baeva, Director of the Global Pharmaceutical Leaders’ Club at the Kazakhstan Pharmaceutical Forum. He outlined Bosnalijek’s development priorities in the Kazakhstan market. Bosnalijek has been actively participating in the Global Pharmaceutical Leaders’ Club conferences for several years and will be the “Pharmaceutical Partner” of the Eurasian Pharmaceutical Summit 2024, set to take place in Tashkent and online on the 17th – 19th September.
Natalia Baeva, Director, Global Pharmaceutical Leaders’ Club: What challenges does your company face today in the Kazakhstan market?
Vladislav Bessarabov, Head of Strategic Business Unit Eurasia, Bosnalijek: We have healthy ambitions to participate more actively in the Kazakhstan market and to develop our portfolio both quantitatively and qualitatively. We aim to independently manage the marketing of our products in Kazakhstan, focusing on our prospects for 2024 and beyond.
There are regulatory challenges related to registration activities in the market, including supranational registration procedures within the EAEU and price regulation. These are tasks we need to address with regulatory authorities, and I am confident we will overcome them.
Natalia Baeva, Director, Global Pharmaceutical Leaders’ Club: How do you benefit from participating in the Global Pharmaceutical Leaders’ Club conferences?
Vladislav Bessarabov, Head of Strategic Business Unit Eurasia, Bosnalijek: The Kazakhstan Pharmaceutical Forum is a unique opportunity to collectively listen to each other, exchange opinions, and discuss one-to-one with colleagues and partners in the supply chain the business tasks we set for ourselves in each country. The word “balance” was mentioned many times at the conference, highlighting the necessity to find equilibrium in these direct discussions to ensure the interests of manufacturers, distributors, pharmacy chains, consumers, and government authorities. This dialogue helps us communicate with colleagues, clear up misconceptions, and find the right path to successfully implement our strategy as a manufacturer.